PharmaOpinionRoche Wants Tissue Images to Do More in Drug Development
Roche’s latest PathAI update connects laboratory workflows with biomarker research and clinical trials, building on its May acquisition agreement.
Pharma · Company
Roche
Covered since Most recent
Roche has updated its PathAI platform to enhance the integration of laboratory workflows with biomarker research and clinical trials, following its acquisition agreement in May. This development aims to leverage tissue images more effectively in drug development.
0Stories
+1 in the last 30 days
0Deployments tracked
1 live
$750 millionacquisition cost
Latest tracker entry
Deployments
In the tracker →- AISight
live$750 million PathAI
Stories
1 storyPharmaOpinion
